ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Thames Ventures Vct 2 Plc

Thames Ventures Vct 2 Plc (D467)

14.00
0.00
( 0.00% )
Updated: 03:00:19

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
14.00
Bid
9.00
Ask
19.00
Volume
0.00
13.50 Day's Range 14.00
13.00 52 Week Range 14.00
Market Cap
Previous Close
14.00
Open
14.00
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
37,745
Shares Outstanding
98,546,959
Dividend Yield
-
PE Ratio
-12.81
Earnings Per Share (EPS)
-0.08
Revenue
-6.02M
Net Profit
-7.66M

About Thames Ventures Vct 2 Plc

Sector
Investment Advice
Industry
Investment Advice
Headquarters
London, Gbr
Founded
1970
Thames Ventures Vct 2 Plc is listed in the Investment Advice sector of the London Stock Exchange with ticker D467. The last closing price for Thames Ventures Vct 2 was 14p. Over the last year, Thames Ventures Vct 2 shares have traded in a share price range of 13.00p to 14.00p.

Thames Ventures Vct 2 currently has 98,546,959 shares outstanding. The market capitalization of Thames Ventures Vct 2 is £13.80 million. Thames Ventures Vct 2 has a price to earnings ratio (PE ratio) of -12.81.

D467 Latest News

PDMR Notification

PDMR Notification THAMES VENTURES VCT 2 PLCLEI: 21380035MV1VRYEXPR95PDMR NOTIFICATION17 JULY 2024 In accordance with Listing Rule 9.6.14, Thames Ventures VCT 2 plc (the “Company”) announces that...

Cancellation of Listing of DSO D Shares and Cessation of Trading

Cancellation of Listing of DSO D Shares and Cessation of Trading THAMES VENTURES VCT 2 PLCDSO D SHARE CLASSLEI: 21380035MV1VRYEXPR95 Cancellation of listing of DSO D Shares and cessation of...

Net Asset Value(s)

Net Asset Value(s) THAMES VENTURES VCT 2 PLCLEI: 21380035MV1VRYEXPR95 NET ASSET VALUES15 MARCH 2024 Thames Ventures VCT 2 plc announces that the unaudited Net Asset Values of its share classes...

Dividend Declaration

Dividend Declaration THAMES VENTURES VCT 2 PLCDSO D SHARE CLASSLEI: 21380035MV1VRYEXPR95 DIVIDEND DECLARATION29 FEBRUARY 2024 The Board of Thames Ventures VCT 2 plc is pleased to declare an...

Half Yearly Results

Half Yearly Results Thames Ventures VCT 2 plcLEI: 21380035MV1VRYEXPR95Half Yearly Results21 December 2023 Financial Highlights  Unaudited30 September 2023pence Unaudited30 September...

Thames Ventures VCT 2 plc Half Yearly Results

7 Thames Ventures VCT 2 plc LEI: 21380035MV1VRYEXPR95 Half Yearly Results 21 December 2023 Financial Highlights Audited 31 Unaudited Unaudited March 30 September 2023 30 September 2022 2023 pence...

Special administration of the Company’s custodian of quoted assets

Special administration of the Company’s custodian of quoted assets THAMES VENTURES VCT 2 PLC (the “Company”)LEI: 21380035MV1VRYEXPR9518 OCTOBER 2023 SPECIAL ADMINISTRATION OF THE COMPANY’S...

Thames Ventures VCT 2 plc Special Administration Of The Company's Custodian Of Quoted Assets

7 THAMES VENTURES VCT 2 PLC (the "Company") LEI: 21380035MV1VRYEXPR95 18 OCTOBER 2023 SPECIAL ADMINISTRATION OF THE COMPANY'S CUSTODIAN OF QUOTED ASSETS Since March 2022, the...

Thames Ventures VCT 2 plc Net Asset Values

7 13 September 2023 Thames Ventures VCT 2 Plc (the "Company") (CRN: 06789187) LEI: 21380035MV1VRYEXPR95 Unaudited Net Asset Values Thames Ventures VCT 2 plc announces that the unaudited...

Thames Ventures VCT 2 plc Company Secretary Change

7 13 September 2023 Thames Ventures VCT 2 Plc (the "Company") (CRN: 06789187) LEI: 21380035MV1VRYEXPR95 Change of Company Secretary and Registered Office Thames Ventures VCT 2 plc is...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100014000DE
400014000DE
1200141413.53774514DE
2600141413.52109014DE
52001414132829114DE
15600141411.72762613.65013527DE
260-21-603542.511.72808719.27162629DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SHIMShimmick Corporation
$ 3.14
(51.69%)
1.62M
ASSTAsset Entities Inc
$ 2.05
(30.57%)
551.92k
MLGOMicroAlgo Inc
$ 3.56
(25.35%)
4.59M
AFARUAura FAT Projects Acquisition Corporation
$ 14.74
(19.55%)
1.13k
APVOAptevo Therapeutics Inc
$ 0.3992
(19.16%)
17.92M
FIVEFive Below Inc
$ 85.00
(-16.72%)
37.74k
HOVRNew Horizon Aircraft Ltd
$ 0.561
(-13.69%)
13.82k
QXOQXO Inc
$ 47.51
(-12.83%)
446
VRPXVirpax Pharmaceuticals Inc
$ 1.32
(-12.58%)
116.48k
LRELead Real Estate Company Ltd
$ 1.84
(-12.38%)
8.69k
APVOAptevo Therapeutics Inc
$ 0.3992
(19.16%)
17.92M
CEROCERo Therapeutics Holdings Inc
$ 0.205
(5.13%)
10.63M
CDTConduit Pharmaceuticals Inc
$ 0.28
(11.51%)
6.76M
MLGOMicroAlgo Inc
$ 3.56
(25.35%)
4.59M
NVDANVIDIA Corporation
$ 122.26
(-3.24%)
2.74M

Discussion

View Full Feed
SCAMBUSTERKING SCAMBUSTERKING 6 minutes ago
Let's flush this out a bit:

- Originally Beard represented Jake and Transitional Matters (Davy) represented SONG, Jake was paying both lawyers to represent him on both sides.
- Davy was legally responsible for protecting SONG and the interest of the company financially, not Jak
SONG
Prestotic Prestotic 6 minutes ago
How and why will it move? Did they report income? PR is nothing new, same old story. Surf and Kev will spread the word. Problem is nobody is interested, and no income. What will 8K tell us? Hopium.
VXIT
ysung ysung 6 minutes ago
Wow these guys are moving fast !!!
HIRU
TheRealMrPirate TheRealMrPirate 6 minutes ago
FKA bioaq Congratulations on your realization 👏
That is 100% the outcome of the CCAA Liquidation process.
Reac Reac 7 minutes ago
Wow so maybe Q2 will contain the whole shebang. Maybe that’s the impending huge news.
IGPK
StevenDice StevenDice 9 minutes ago
Largely true. However, when a Tier 1 is adopting a novel technology, that information, while not directly disclosed, begins to move the share price via the engineers, consultants, foundry technicians, product designers, procurement administrators and all manor of tertiary personnel who can read the
LWLG
louieforpar louieforpar 10 minutes ago
As always…Thank you Eli!!


Hovland
McCilroy
Finau
Fleetwood
Fitzpatrick

Tiebreaker:274

GLTA
CaptainObvious CaptainObvious 11 minutes ago
07/17/24 - 1,233,314,821
07/13/24 - 1,232,214,821
07/11/24 - 1,231,614,821
07/10/24 - 1,230,455,122
06/29/24 - 1,229,682,280
06/19/24 - 1,229,013,505
06/13/24 - 1,226,621,118
06/11/24 - 1,226,070,527
06/06/24 - 1,224,429,027
06/05/24 - 1
NWBO
Large Green Large Green 12 minutes ago
JHD, very smart! The reason things are made difficult in many situations is they are trying to take something from you and/or obfuscate for nefarious reasons.

COOP
stink stack stink stack 13 minutes ago
Stop drinking booze
FNMA
$Green$ $Green$ 14 minutes ago
AI options, about to bank
SPY
Bull_Dolphin Bull_Dolphin 14 minutes ago
Cheatle should resign for even saying such a stupid thing about a low sloped roof.
surfkast surfkast 15 minutes ago
Why are you laughed off all the others boards as a basher but keep pumping this POS with Hopium?
I don't believe in fake emails or anything on X or any social media designed for scammer pumpers.
Need to see PR's and or filings with links to proven facts. The real verifiable DD here is
MWWC
snootmagruder snootmagruder 15 minutes ago
Hi JK, I have current right now at 2293 with the previous ATH at 2460 and you're predicting 2820 - correct?
MasterBlastr MasterBlastr 15 minutes ago
That I see it as an elephant before anything else - you got a point. How incredibly prolific some authors can be.
Mufaso Mufaso 17 minutes ago
Roche said it's oral qd obesity drug CT-996 demonstrated "clinically meaningful weight loss of -7.3% after four weeks of treatment" or -6.1% PBO adjusted.,(weight loss in placebo -1.2%; p < 0.001). They didn't release any tolerability data with the presser which is the norm for large pharma but
TommyBoyTrader9460 TommyBoyTrader9460 17 minutes ago
$TKLF
https://x.com/autumnsdad1/status/1813517268200091687?s=61
TKLF
Edward Edward 18 minutes ago
Citius Pharmaceuticals Inc (CTXR)

Since the close of 7/3/2024 (.485), CTXR is up 75.25% with yesterday's close @.85.

Quite impressive.
CTXR
JamesF1 JamesF1 20 minutes ago
You are correct that Tylenol with codeine and Methotrexate come first. My hope is that Norco generic gets launched shortly after those two.
ELTP
capgain capgain 21 minutes ago
Snowy White - Midnight Blues (High-Quality Sound)

https://www.youtube.com/watch?v=AWB2alXccWg
LuckyLovie LuckyLovie 21 minutes ago
I've been scouring all news business feed Outlets all last night several diff countries and Wowwwww it will knock your soxs off....this is BIG GYNORMUS NEWS...HITTING TODAY...ITS...












the company has
IGPK
JusDePomme JusDePomme 21 minutes ago
I m not sure about u but I start to get tick off this CEO here. He has many years to get company moving but still in development mode. Look at gtvh CEO! He just get it done in months pps .0004 move to .01+ high last
ICNM
GVInvestments GVInvestments 22 minutes ago
aaa aaa aaa aaa aaa aaaa aaaa aaaa aaa aaaaa aaa aaaa
FNMA